0.7750
-0.0500
(-6.06%)
At close: 4:18:58 PM GMT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Peter Joseph Sargent | CEO, COO & Director | 93.33k | -- | 1978 |
| Prof. David Fell | Co-Founder & Member of Scientific Advisory Board | -- | -- | -- |
| Mr. Anthony Louis Clayden ACA, BSc (Hons), MSI | Head of Finance & Company Secretary | -- | -- | 1968 |
| Ms. Hayley Close | Head of Business Development | -- | -- | -- |
| Dr. Venkata Putcha | Head of Biostatistics | -- | -- | -- |
| Dr. Mark Davies | Head of Quantitative Pharmacology & Data Science | -- | -- | -- |
| Dr. Mark Middleton M.D., Ph.D. | Consultant & Member of Scientific Advisory Board | -- | -- | -- |
| Dr. Robert Jackson Ph.D. | Consultant & Member of Scientific Advisory Board | -- | -- | 1944 |
Physiomics Plc
Bee House
140 Eastern Avenue Milton Park
Oxford, OX14 4SB
United Kingdom
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 11
Description
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Corporate Governance
Physiomics Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 5, 2025 at 8:30 AM UTC - March 10, 2025 at 8:30 AM UTC
Physiomics Plc Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
TCF.L Theracryf Plc
0.7750
+3.33%
FAB.L Fusion Antibodies plc
9.25
+1.65%
VAL.L ValiRx plc
0.6750
0.00%
GENF.L Genflow Biosciences plc
1.9250
0.00%
SAR.L Sareum Holdings plc
22.00
-2.22%
SNG.L Synairgen plc
2.2450
+7.54%
PASG Passage Bio, Inc.
0.6350
-5.22%
NNVC NanoViricides, Inc.
1.2399
-8.16%
ARQT Arcutis Biotherapeutics, Inc.
13.68
-0.98%
ARGX argenx SE
663.99
+1.18%